Chylomicron Retention Disease in A Male Infant: A Rare Case from Pakistan

Sohail Kumar1, Deedar Nanjiani2, Faryal Tahir2

  • 1Internal Medicine, Dow Medical College and Dr. Ruth K. M. Pfau Civil Hospital Karachi, Karachi, PAK.

Cureus
|April 8, 2020
PubMed

Insights

Chylomicron retention disease (CMRD), a genetic disorder, can be challenging to diagnose early. Dietary changes with medium- and short-chain fatty acids offer a crucial therapeutic trial for diagnosis and management, especially in resource-limited settings.

Area of Science:

  • Genetics and Molecular Biology
  • Pediatric Gastroenterology
  • Rare Disease Research

Background:

  • Chylomicron retention disease (CMRD), or Anderson's disease, is an autosomal recessive disorder caused by mutations in the SAR1B gene.
  • Classic symptoms include steatorrhea, vomiting, failure to thrive, and abdominal bloating, typically presenting in infancy or childhood.

Observation:

  • A 50-day-old male infant initially presented with non-specific symptoms mimicking acute gastroenteritis and sepsis.
  • Despite initial management, the infant's condition deteriorated, prompting further investigation.
  • Diagnostic clues included lipid profiles, clinical presentation, and pathological findings suggestive of CMRD.

Findings:

  • A presumptive diagnosis of CMRD was established based on clinical and laboratory findings.
  • The patient demonstrated significant clinical improvement following a therapeutic trial of medium- and short-chain fatty acids.
  • This highlights the diagnostic and therapeutic value of dietary interventions in CMRD.

Implications:

  • In resource-restricted settings, a dietary trial with medium- and short-chain fatty acids is crucial for diagnosing CMRD.
  • Early diagnosis and intervention can prevent severe complications associated with chylomicron retention.
  • This approach supports timely management in areas with limited diagnostic resources.